Clinical Trial Update: Myocardial Protection With Adenosine Preconditioning [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial investigating adenosine preconditioning for myocardial protection during congenital heart defect repair and cardiac surgery has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects
• Myocardial Reperfusion Injury

Drugs mentioned

• Adenosine (Adenosine)

Snippet

Sponsor: Xijing Hospital | Conditions: Heart Defects, Congenital, Cardiac Surgical Procedures | Phase 1, Phase 2 | Status: COMPLETED